Literature DB >> 34715703

Aggressive systemic mastocytosis with diffuse bone marrow 18F-FDG uptake.

Renata Koukalová1,2, Jiří Vašina1,2, Jiří Štika3, Michael Doubek4,2, Petr Szturz5.   

Abstract

Mastocytosis is a clonal hematopoietic disorder characterized by proliferation of abnormal mast cells in various organs including the skin, digestive system, lymph nodes, and bone marrow. We report on a 75-year-old woman presenting with abdominal pain, vomiting, diarrhoea, myalgia, and weight loss. Abdominal CT showed hepatosplenomegaly with heterogeneous splenic parenchyma, lymphadenopathy, and osteopenia with areas of osteosclerosis but no primary tumour. An 18F-FDG PET/CT revealed an overall low metabolic activity of the lesions with a diffuse bone marrow involvement raising suspicion of a haematological neoplasm. Subsequently, bone marrow and peripheral blood examinations confirmed the diagnosis of aggressive systemic mastocytosis. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34715703     DOI: 10.1055/a-1650-9704

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  1 in total

1.  Systemic Mastocytosis Treatment with Midostaurin: [18F]FDG PET/CT as a Potential Monitoring Tool for Therapy Outcome.

Authors:  Caroline Burgard; Florian Rosar; Fadi Khreish; Samer Ezziddin
Journal:  Diagnostics (Basel)       Date:  2022-03-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.